Friday, February 17, 2012

April price cut to wipe $7bn off Japanese drug market

The next biennial revision of drug reimbursement prices in Japan in April will slash around ¥550 billion ($7 billion) from the nation's medicines budget, a saving that will be used to balance out planned increases in medical fees.

Posted via email from Jack's posterous

No comments: